Two Sigma Investments’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,706
Closed -$30.4K 4296
2025
Q3
$30.4K Sell
14,706
-15,892
-52% -$34.2K ﹤0.01% 3571
2025
Q2
$75.6K Sell
30,598
-61,026
-67% -$144K ﹤0.01% 3027
2025
Q1
$115K Buy
91,624
+26,474
+41% +$96.5K ﹤0.01% 2949
2024
Q4
$210K Buy
65,150
+6,993
+12% +$24.7K ﹤0.01% 2867
2024
Q3
$182K Buy
58,157
+39,875
+218% +$130K ﹤0.01% 2815
2024
Q2
$57.4K Buy
+18,282
New +$67.4K ﹤0.01% 2875

Two Sigma Investments's MURA Position: Q4 2025 in Review

Two Sigma Investments sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 14,706 shares — an estimated $30.4K sold.

Two Sigma Investments first reported a position in MURA in Q2 2024 and held it in 6 quarters. The position peaked at $210K in Q4 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • Two Sigma Investments reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 14,706 Mural Oncology shares in Q4 2025, an estimated $30.4K.
  • Two Sigma Investments first reported a position in Mural Oncology in Q2 2024 and held it in 6 quarters.
  • Two Sigma Investments's Mural Oncology position peaked at $210K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.